Del Monte Pacific (D03) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
11 Sep, 2026Executive summary
Group sales rose 4% year-over-year to $537 million, driven by strong international and Philippine market performance, with DMPI achieving a 13% sales increase in peso terms and a 52% net profit rise.
Group net loss was $34.2 million, mainly due to high costs and increased interest expense in the US subsidiary, but losses were more than halved sequentially from the previous quarter.
Recovery in the Philippines was supported by new leadership, increased marketing, and operational improvements.
U.S. operations faced headwinds but saw stabilization in core categories and growth in Joyba Boba tea.
Financial highlights
Turnover rose to $536.9 million from $516.7 million year-over-year, but gross profit declined 19% to $87.6 million, with gross margin at 16.3%.
DMPI operating profit up 46% to $27.7 million; net profit up 52% to $17.3 million.
International sales grew 20% year-over-year, led by fresh fruit exports to China, Korea, and Japan.
Net debt reduced to $2,226.2 million from $2,299.7 million due to better inventory management.
Cash flow from operations improved to $74.7 million, up from $47.5 million year-over-year.
Outlook and guidance
Philippine business expects continued strong performance, with further marketing investments and new product launches planned through FY2028.
U.S. business anticipates margin improvement in the second half of FY2025 and significant benefits in FY2026 as high-cost inventory is cleared and cost reductions take effect.
Plans for selective US asset sales and equity injection via strategic partnerships to lower leverage.
Full financial impact of initiatives expected in FY2026; FY2025 net loss anticipated but lower than FY2024.
Fresh pineapple exports expected to grow at mid- to high double-digit CAGR through FY2028.
Latest events from Del Monte Pacific
- Net profit surged 192.6% on 9% higher sales, with restructuring underway to address negative equity.D03
Q1 2027 - Strong FY2026 growth and profitability, but negative equity restricts dividends.D03
Q4 2026 - Strong sales and margin gains offset U.S. exit, but negative equity and capital deficit persist.D03
Q3 2026 - Q2 net profit surged 631.6% as Asian operations and fresh exports fueled strong growth.D03
Q2 2026 - Sales and profit surged, margins and debt improved, with profitability expected for FY2026.D03
Q1 2026 - U.S. deconsolidation and Asian growth drove profitability and capital restructuring.D03
Q4 2025 - Sales up 4% but net loss widened to US$56m on higher costs and U.S. subsidiary challenges.D03
Q2 2025 - Net loss widened to $127m on flat sales; margin recovery and asset sales targeted in FY25.D03
Q4 2024 - Turnover rose but net losses deepened, with Asia Pacific growth offset by U.S. challenges.D03
Q3 2025